Humoral immunity studies
| . | WHN−/−recipient . | WHN+/− donor . |
|---|---|---|
| Serum IgG (g/L) | 4.94 | 6.55 |
| Serum IgA (g/L) | 0.49 | 0.77 |
| Serum IgM (g/L) | 0.80 | 0.74 |
| Autoantibodies | abs | abs |
| Specific antibodies | ||
| Allohemoagglutinins | ||
| Pre-BMT | abs | anti-A/B (1:128) |
| Post-BMT | anti-A (1:8) | |
| Tetanus toxoid | ||
| Pre-BMT | abs | pos |
| Post-BMT | pos | pos |
| HbsAg | ||
| Pre-BMT | abs | abs |
| Post-BMT | pos | pos |
| . | WHN−/−recipient . | WHN+/− donor . |
|---|---|---|
| Serum IgG (g/L) | 4.94 | 6.55 |
| Serum IgA (g/L) | 0.49 | 0.77 |
| Serum IgM (g/L) | 0.80 | 0.74 |
| Autoantibodies | abs | abs |
| Specific antibodies | ||
| Allohemoagglutinins | ||
| Pre-BMT | abs | anti-A/B (1:128) |
| Post-BMT | anti-A (1:8) | |
| Tetanus toxoid | ||
| Pre-BMT | abs | pos |
| Post-BMT | pos | pos |
| HbsAg | ||
| Pre-BMT | abs | abs |
| Post-BMT | pos | pos |
abs, absent; pos, positive.